Log in to save to my catalogue

India's ban on antimicrobial fixed-dose combinations: winning the battle, losing the war?

India's ban on antimicrobial fixed-dose combinations: winning the battle, losing the war?

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a1cd68ed9b4f48a0b4010c37937d880c

India's ban on antimicrobial fixed-dose combinations: winning the battle, losing the war?

About this item

Full title

India's ban on antimicrobial fixed-dose combinations: winning the battle, losing the war?

Publisher

England: BioMed Central Ltd

Journal title

Journal of pharmaceutical policy and practice, 2022-04, Vol.15 (1), p.33-33, Article 33

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

India, the country with the largest market availability of antimicrobial fixed-dose combinations (FDCs), banned certain antimicrobial FDCs in September 2018. Our objective was to examine the impact of Government ban on the sales of antimicrobial FDCs.
The sales patterns of 14 of the 26 banned antimicrobial FDCs were analyzed using monthly privat...

Alternative Titles

Full title

India's ban on antimicrobial fixed-dose combinations: winning the battle, losing the war?

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_a1cd68ed9b4f48a0b4010c37937d880c

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a1cd68ed9b4f48a0b4010c37937d880c

Other Identifiers

ISSN

2052-3211

E-ISSN

2052-3211

DOI

10.1186/s40545-022-00428-w

How to access this item